江中药业2025年实现归属净利润9.06亿元，同比增长14.96%

Core Viewpoint - Jiangzhong Pharmaceutical (600750) reported a revenue of 4.22 billion yuan for 2025, a year-on-year decrease of 4.87%, while net profit attributable to shareholders reached 906 million yuan, reflecting a year-on-year increase of 14.96% [1] Group 1: Financial Performance - The company achieved an operating income of 4.22 billion yuan in 2025, which is a decrease of 4.87% compared to the previous year [1] - The net profit attributable to shareholders was 906 million yuan, showing a growth of 14.96% year-on-year [1] Group 2: Strategic Initiatives - The company is focusing on brand development and strengthening its core business around "big single products and strong categories" to address structural adjustment pressures in the industry [1] - Jiangzhong Pharmaceutical is enhancing its marketing strategies, optimizing cost structures, and deepening lean manufacturing to improve profitability [1]